A Gemini-powered personal health coach is available in preview for Fitbit Premium subscribers. I let it plan my workouts for ...
From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...
If you are wondering whether ResMed is still attractive after its strong run, or if the market has already priced in the upside, this article will help you cut through the noise and focus on what the ...
This branded content article is sponsored by Movement. Tired of restless nights and waking up feeling anything but refreshed? The secret to truly restorative sleep often lies in your sleep essentials, ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Resmed is looking to new innovations to give the sleep ...
A recent PLoS One study used data from participants from sleep clinics to assess the performance of a consumer-grade sleep-tracking device, relative to polysomnography (PSG). The importance of sleep ...
Test your knowledge with this quiz. Test your knowledge with this quiz. Credit... Supported by By Caroline Hopkins Legaspi Illustrations by Hoi Chan For an activity most of us spend about a third of ...
In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. ResMed Inc. is placed fourth among them. ResMed Inc. (NYSE:RMD) is a leading health technology company ...
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the ...
ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.
YARMOUTH, Maine – CPAP providers say they can’t fault Resmed for expanding its reach into the sleep market, but there’s always concern that a “Goliath” will eventually muscle smaller companies out of ...
ResMed (ASX: RMD) has reported double-digit earnings per share (EPS) growth for the three months to March on the back of increasing market demand for its best-in-class sleep apnoea products and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results